These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37955640)

  • 1. Identification of a carbohydrate recognition motif of purinergic receptors.
    Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
    Elife; 2023 Nov; 12():. PubMed ID: 37955640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UDP-sugars activate P2Y
    Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
    Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M; Dickenson JM
    Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.
    Lee SA; Park JH; Lee SY
    Mol Cells; 2013 Sep; 36(3):273-7. PubMed ID: 24048691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
    Scrivens M; Dickenson JM
    Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.
    Carter RL; Fricks IP; Barrett MO; Burianek LE; Zhou Y; Ko H; Das A; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2009 Dec; 76(6):1341-8. PubMed ID: 19759354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.
    Scrivens M; Dickenson JM
    Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of UDP-Sugar Receptor P2Y
    Mikolajewicz N; Komarova SV
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y
    Lin J; Liu F; Zhang YY; Song N; Liu MK; Fang XY; Liao DQ; Zhou C; Wang H; Shen JF
    J Cell Physiol; 2019 Nov; 234(11):21199-21210. PubMed ID: 31032956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
    Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G
    Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.
    Lazarowski ER; Harden TK
    Mol Pharmacol; 2015 Jul; 88(1):151-60. PubMed ID: 25829059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empowering human cardiac progenitor cells by P2Y
    Khalafalla FG; Kayani W; Kassab A; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Norman B; Dembitsky WP; Sussman MA
    J Physiol; 2017 Dec; 595(23):7135-7148. PubMed ID: 28980705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatography-mass spectrometry assay for the quantification of nucleotide sugars in human plasma and urine specimens and its clinical application.
    Caron P; Nguyen Van Long F; Rouleau M; Bujold E; Fortin P; Mohammadi S; Lévesque É; Breton S; Guillemette C
    J Chromatogr A; 2022 Aug; 1677():463296. PubMed ID: 35820232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
    Qi AD; Harden TK; Nicholas RA
    J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP is a competitive antagonist at the human P2Y14 receptor.
    Fricks IP; Maddileti S; Carter RL; Lazarowski ER; Nicholas RA; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2008 May; 325(2):588-94. PubMed ID: 18252808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems.
    Fricks IP; Carter RL; Lazarowski ER; Harden TK
    J Pharmacol Exp Ther; 2009 Jul; 330(1):162-8. PubMed ID: 19339661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells.
    Katakura S; Takao T; Arase T; Yoshimasa Y; Tomisato S; Uchida S; Masuda H; Uchida H; Tanaka M; Maruyama T
    Placenta; 2020 Nov; 101():194-203. PubMed ID: 33011563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.